Total Payments
$10,587
2024 Payments
$806.37
Companies
28
Transactions
542
Medicare Patients
8,722
Medicare Billing
$394,476
Payment Breakdown by Category
Food & Beverage$9,452 (89.3%)
Travel$1,124 (10.6%)
Education$11.97 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,452 | 534 | 89.3% |
| Travel and Lodging | $1,124 | 6 | 10.6% |
| Education | $11.97 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,719 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,702 | 111 | $0 (2024) |
| Amgen Inc. | $1,190 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,100 | 63 | $0 (2024) |
| Boston Scientific Corporation | $1,017 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $869.74 | 70 | $0 (2023) |
| ABIOMED | $567.48 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $385.15 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $340.45 | 21 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $325.80 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $806.37 | 31 | Philips North America LLC ($149.13) |
| 2023 | $1,167 | 64 | Novartis Pharmaceuticals Corporation ($209.65) |
| 2022 | $3,074 | 96 | Abbott Laboratories ($1,568) |
| 2021 | $1,517 | 86 | BOSTON SCIENTIFIC CORPORATION ($380.99) |
| 2020 | $1,047 | 65 | AstraZeneca Pharmaceuticals LP ($304.75) |
| 2019 | $727.09 | 45 | AstraZeneca Pharmaceuticals LP ($165.24) |
| 2018 | $1,176 | 82 | Novartis Pharmaceuticals Corporation ($286.79) |
| 2017 | $1,073 | 73 | Novartis Pharmaceuticals Corporation ($329.84) |
All Payment Transactions
542 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Structural Heart | ||||||
| 11/20/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: WATCHMAN_IC | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Heart Failure | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Heart Failure | ||||||
| 09/11/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| Category: Cardiovascular | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: CARDIOLOGY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $74.57 | General |
| Category: Medical Device | ||||||
| 06/24/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $74.56 | General |
| Category: Medical Device | ||||||
| 06/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.41 | General |
| 05/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiology | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: Cardiovascular | ||||||
| 04/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Cardiovascular | ||||||
| 04/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,739 | 1,879 | $394,176 | $87,061 |
| 2022 | 29 | 2,002 | 2,155 | $328,000 | $99,237 |
| 2021 | 26 | 2,449 | 2,649 | $362,152 | $109,796 |
| 2020 | 27 | 2,532 | 2,746 | $333,539 | $98,382 |
Total Patients
8,722
Total Services
9,429
Medicare Billing
$394,476
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 309 | $89,919 | $20,004 | 22.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 50 | $42,350 | $10,527 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 170 | 170 | $33,150 | $8,399 | 25.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 138 | 141 | $28,491 | $6,853 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 62 | $26,350 | $6,309 | 23.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 60 | $16,980 | $5,427 | 32.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 39 | $21,918 | $5,142 | 23.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 87 | 87 | $23,316 | $4,638 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $22,748 | $4,054 | 17.8% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $11,436 | $2,945 | 25.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 34 | 35 | $16,485 | $2,751 | 16.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 230 | 260 | $8,580 | $1,414 | 16.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 23 | $4,600 | $1,383 | 30.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 87 | 87 | $8,526 | $1,295 | 15.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 15 | 16 | $7,856 | $1,275 | 16.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 87 | 87 | $5,655 | $861.03 | 15.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 116 | 131 | $5,240 | $761.38 | 14.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 71 | 71 | $9,230 | $667.40 | 7.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 20 | 20 | $1,600 | $580.80 | 36.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 19 | 20 | $1,400 | $378.00 | 27.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 28 | 28 | $1,484 | $364.23 | 24.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 18 | $1,224 | $308.91 | 25.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 14 | $1,778 | $226.92 | 12.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 21 | 21 | $1,054 | $173.85 | 16.5% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 16 | 16 | $1,728 | $139.84 | 8.1% |
About Dr. John Powers, MD
Dr. John Powers, MD is a Cardiovascular Disease healthcare provider based in Winston-Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235199258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Powers, MD has received a total of $10,587 in payments from pharmaceutical and medical device companies, with $806.37 received in 2024. These payments were reported across 542 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,452).
As a Medicare-enrolled provider, Powers has provided services to 8,722 Medicare beneficiaries, totaling 9,429 services with total Medicare billing of $394,476. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Winston-Salem, NC
- Active Since 03/24/2006
- Last Updated 10/24/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1235199258
Products in Payments
- CARDIOMEMS (Device) $1,617
- ENTRESTO (Drug) $1,488
- XARELTO (Drug) $869.74
- Repatha (Biological) $747.71
- BRILINTA (Drug) $746.63
- Impella (Device) $567.48
- WATCHMAN (Device) $504.98
- WATCHMAN Access System (Device) $431.46
- Corlanor (Drug) $419.69
- ELIQUIS (Drug) $406.86
- LifeVest (Device) $325.80
- JARDIANCE (Drug) $304.17
- LEQVIO (Drug) $213.88
- LOKELMA (Drug) $176.09
- (CK4) MCOT (Device) $149.13
- CAMZYOS (Drug) $121.56
- FARXIGA (Drug) $115.81
- VITALPATCH RTM (Device) $112.87
- VERQUVO (Drug) $112.52
- MULTAQ (Drug) $102.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.